Our findings identified SNPs significantly associated with disease risk, demonstrated altered expression of immune (IL-6, IL-8), antioxidant (SOD3, HMOX1), and lipogenic (ACACA, FASN) genes, and confirmed hepatic steatosis via ultrasonography. This evidence concerns the gene FASN and fatty liver disease.